Key result
Implantable cardioverter defibrillator implantation rates vary greatly by geography, with 185 implants per million inhabitants in the United States compared to 31 per million in western Europe.
Significant geographic disparities exist in ICD implantation rates between the US and Western Europe, influenced by medical, economic, and political factors.
Answers are grounded in this paper and cite their sources.
Geographic ICD rate disparities may signal access inequities; leaves open optimal benchmarks and outcome effects.
Despite the demonstrated efficacy of implantable cardioverter defibrillators (ICDs) in reducing sudden and total mortality in selected patients, their implantation rates vary greatly among countries. In the United States, the implantation rate is 185 implants per million inhabitants compared with only 31 implants per million in western Europe. The differences in ICD use may be explained by the following factors: manner in which sudden cardiac death is perceived by politicians and physicians (sudden cardiac death is perceived as a "nice way of dying"); differences in indications; physicians' information; prevalence of coronary artery disease; sudden cardiac death survival rates; perceived reliability of alternative treatment (namely, antiarrhythmics including amiodarone); economic backgrounds; and health care politics. Furthermore, the cost of this treatment strategy must be considered. This issue has been raised because generalization of ICD use in patients matching clinical characteristics of patients enrolled in the primary prevention trials may represent a significant economic burden to be added to the already overloaded health care system. This low acceptance may not be entirely related to budget constraint but also to the perceived efficacy of ICDs by physicians and health authorities.
No takes yet. Share an insight, caveat, or question.
Seidl et al. (2002) conducted a review in Sudden cardiac death. Implantable Cardioverter Defibrillators was evaluated on Implantation rate per million inhabitants. Implantable cardioverter defibrillator implantation rates vary greatly by geography, with 185 implants per million inhabitants in the United States compared to 31 per million in western Europe.
Synapse has enriched 10 related papers. Consider them for comparative context: